PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 6, Pages 2061
Publisher
MDPI AG
Online
2020-03-18
DOI
10.3390/ijms21062061
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current status, problems, and perspectives of non-alcoholic fatty liver disease research
- (2019) Naoki Tanaka et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPAR-α and insulin-dependent signalling in hepatocytes
- (2019) S. Smati et al. DIABETES & METABOLISM
- Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner
- (2019) Zhuo Wei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
- (2018) Xavier Palomer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Vitamin D prevents lipid accumulation in murine muscle through regulation of PPARγ and perilipin-2 expression
- (2018) Jiarong Li et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- GW0742 (PPAR-beta agonist) attenuates hepatic endoplasmic reticulum stress by improving hepatic energy metabolism in high-fat diet fed mice
- (2018) Flavia Maria Silva-Veiga et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis
- (2018) Alexandre Vallée et al. Frontiers in Immunology
- Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
- (2018) Mohammad Zarei et al. Molecular Metabolism
- Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice
- (2018) Chad N. Brocker et al. JOURNAL OF LIPID RESEARCH
- PPARα protects against trans -fatty-acid-containing diet-induced steatohepatitis
- (2017) Xiao Hu et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Targeting nuclear receptors for the treatment of fatty liver disease
- (2017) Naoki Tanaka et al. PHARMACOLOGY & THERAPEUTICS
- Decreased Fatty Acid β-Oxidation Is the Main Cause of Fatty Liver Induced by Polyunsaturated Fatty Acid Deficiency in Mice
- (2017) Takero Nakajima et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Synthesis of 5-trifluoromethyl-2-sulfonylpyridine PPARβ/δ antagonists: Effects on the affinity and selectivity towards PPARβ/δ
- (2016) Åsmund Kaupang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells
- (2016) Maria Antonietta Ajmone-Cat et al. BRAIN BEHAVIOR AND IMMUNITY
- Fatty acids, eicosanoids and PPAR gamma
- (2016) Rachel Marion-Letellier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Age-dependent PPARα activation induces hepatic sulfatide accumulation in transgenic mice carrying the hepatitis C virus core gene
- (2016) Yangyang Tian et al. GLYCOCONJUGATE JOURNAL
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice
- (2016) Gayathri Balandaram et al. TOXICOLOGY
- Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα
- (2015) Michiharu Komatsu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet
- (2015) Naoki Tanaka et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The effect of bioactive compounds in tea on lipid metabolism and obesity through regulation of peroxisome proliferator-activated receptors
- (2015) Sung-Joon Lee et al. CURRENT OPINION IN LIPIDOLOGY
- Synthesis, biological evaluation and molecular modeling studies of the PPARβ/δ antagonist CC618
- (2015) Åsmund Kaupang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
- (2015) Sven Francque et al. JOURNAL OF HEPATOLOGY
- Establishing the Role of PPARβ/δ in Carcinogenesis
- (2015) Jeffrey M. Peters et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease
- (2015) Hyun Jung Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
- (2015) Ling Chen et al. Oncotarget
- Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway
- (2015) Ning Zhang et al. Oncotarget
- Adipocyte-specific Disruption of Fat-specific Protein 27 Causes Hepatosteatosis and Insulin Resistance in High-fat Diet-fed Mice
- (2014) Naoki Tanaka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα
- (2014) Yan Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- PPARδ activation attenuates hepatic steatosis inLdlr−/−mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
- (2014) Lazar A. Bojic et al. JOURNAL OF LIPID RESEARCH
- Inventing new medicines: The FGF21 story
- (2014) Alexei Kharitonenkov et al. Molecular Metabolism
- Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study
- (2013) J. Christopher Corton et al. CRITICAL REVIEWS IN TOXICOLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells
- (2013) Eva Morán-Salvador et al. JOURNAL OF HEPATOLOGY
- A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use
- (2013) Sihao Liu et al. NATURE
- PPARγ signaling and metabolism: the good, the bad and the future
- (2013) Maryam Ahmadian et al. NATURE MEDICINE
- From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
- (2013) Alexander Wree et al. Nature Reviews Gastroenterology & Hepatology
- Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPAR
- (2013) F. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adiponectin, driver or passenger on the road to insulin sensitivity?
- (2013) Risheng Ye et al. Molecular Metabolism
- Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs
- (2012) Takero Nakajima et al. GLYCOCONJUGATE JOURNAL
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist
- (2012) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nuclear receptor PPAR -regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis
- (2012) Y. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARs at the crossroads of lipid signaling and inflammation
- (2012) Walter Wahli et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Hepatic Cerebroside Sulfotransferase Is Induced by PPARα Activation in Mice
- (2012) Takefumi Kimura et al. PPAR Research
- The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
- (2011) Emma Barroso et al. ENDOCRINOLOGY
- Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts
- (2011) Eva Morán-Salvador et al. FASEB JOURNAL
- Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy
- (2011) Naoki Tanaka et al. JOURNAL OF GASTROENTEROLOGY
- PPARα Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver
- (2011) Mohamed A. Abdelmegeed et al. JOURNAL OF NUTRITION
- Peroxisome Proliferator-Activated Receptor δ Regulates Inflammation via NF-κB Signaling in Polymicrobial Sepsis
- (2010) Basilia Zingarelli et al. AMERICAN JOURNAL OF PATHOLOGY
- Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new PPARγ agonist KR62776
- (2010) Myung-Ae Bae et al. ARCHIVES OF PHARMACAL RESEARCH
- PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells
- (2010) David Álvarez-Guardia et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- PPARγ in Placental Angiogenesis
- (2010) Karim Nadra et al. ENDOCRINOLOGY
- Leukotriene B4Is a Physiologically Relevant Endogenous Peroxisome Proliferator-activated Receptor-α Agonist
- (2010) Venkata R. Narala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Down-regulation of SREBP-1c is associated with the development of burned-out NASH
- (2010) Tadanobu Nagaya et al. JOURNAL OF HEPATOLOGY
- An increase in liver PPARγ2 is an initial event to induce fatty liver in response to a diet high in butter: PPARγ2 knockdown improves fatty liver induced by high-saturated fat
- (2010) Tomomi Yamazaki et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Hepatic Steatosis in Leptin-Deficient Mice Is Promoted by the PPARγ Target Gene Fsp27
- (2008) Kimihiko Matsusue et al. Cell Metabolism
- Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
- (2008) Xiaomei Qin et al. HEPATOLOGY
- Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease
- (2008) Michiharu Komatsu et al. JOURNAL OF HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started